Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.

Shinohara M, Io K, Shindo K, Matsui M, Sakamoto T, Tada K, Kobayashi M, Kadowaki N, Takaori-Kondo A.

Sci Rep. 2012;2:806. doi: 10.1038/srep00806. Epub 2012 Nov 13.

2.

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.

Akre MK, Starrett GJ, Quist JS, Temiz NA, Carpenter MA, Tutt AN, Grigoriadis A, Harris RS.

PLoS One. 2016 May 10;11(5):e0155391. doi: 10.1371/journal.pone.0155391. eCollection 2016.

3.

Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.

Caval V, Bouzidi MS, Suspène R, Laude H, Dumargne MC, Bashamboo A, Krey T, Vartanian JP, Wain-Hobson S.

Nucleic Acids Res. 2015 Oct 30;43(19):9340-9. doi: 10.1093/nar/gkv935. Epub 2015 Sep 17.

4.

Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.

Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, Candinas D, Sommer P, Wain-Hobson S, Vartanian JP, Greeve J.

Hepatology. 2006 Jun;43(6):1364-74.

PMID:
16729314
5.

APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.

Ooms M, Krikoni A, Kress AK, Simon V, Münk C.

J Virol. 2012 Jun;86(11):6097-108. doi: 10.1128/JVI.06570-11. Epub 2012 Mar 28.

6.

Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.

Bogerd HP, Kornepati AV, Marshall JB, Kennedy EM, Cullen BR.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):E7249-56. doi: 10.1073/pnas.1516305112. Epub 2015 Dec 14.

7.

Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.

Verhalen B, Starrett GJ, Harris RS, Jiang M.

J Virol. 2016 Jun 24;90(14):6379-6386. doi: 10.1128/JVI.00771-16. Print 2016 Jul 15.

8.

Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6.

Mori S, Takeuchi T, Ishii Y, Kukimoto I.

Biochem Biophys Res Commun. 2015 May 8;460(3):555-60. doi: 10.1016/j.bbrc.2015.03.068. Epub 2015 Mar 20.

PMID:
25800874
9.

APOBEC3B cytidine deaminase targets the non-transcribed strand of tRNA genes in yeast.

Saini N, Roberts SA, Sterling JF, Malc EP, Mieczkowski PA, Gordenin DA.

DNA Repair (Amst). 2017 May;53:4-14. doi: 10.1016/j.dnarep.2017.03.003. Epub 2017 Mar 21.

10.

Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.

Zhang W, Zhang X, Tian C, Wang T, Sarkis PT, Fang Y, Zheng S, Yu XF, Xu R.

Cell Microbiol. 2008 Jan;10(1):112-21. Epub 2007 Aug 1.

PMID:
17672864
11.

Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

Byeon IJ, Byeon CH, Wu T, Mitra M, Singer D, Levin JG, Gronenborn AM.

Biochemistry. 2016 May 31;55(21):2944-59. doi: 10.1021/acs.biochem.6b00382. Epub 2016 May 19.

12.

APOBEC3B and AID have similar nuclear import mechanisms.

Lackey L, Demorest ZL, Land AM, Hultquist JF, Brown WL, Harris RS.

J Mol Biol. 2012 Jun 22;419(5):301-14. doi: 10.1016/j.jmb.2012.03.011. Epub 2012 Mar 23.

13.

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.

Periyasamy M, Singh AK, Gemma C, Kranjec C, Farzan R, Leach DA, Navaratnam N, Pálinkás HL, Vértessy BG, Fenton TR, Doorbar J, Fuller-Pace F, Meek DW, Coombes RC, Buluwela L, Ali S.

Nucleic Acids Res. 2017 Nov 2;45(19):11056-11069. doi: 10.1093/nar/gkx721.

14.

APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.

Cescon DW, Haibe-Kains B, Mak TW.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2841-6. doi: 10.1073/pnas.1424869112. Epub 2015 Feb 17.

15.

DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.

Fu Y, Ito F, Zhang G, Fernandez B, Yang H, Chen XS.

Biochem J. 2015 Oct 1;471(1):25-35. doi: 10.1042/BJ20150382. Epub 2015 Jul 20.

16.

Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.

Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A.

Biochem Biophys Res Commun. 2016 Sep 23;478(3):1466-71. doi: 10.1016/j.bbrc.2016.08.148. Epub 2016 Aug 27.

17.

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.

Suspène R, Guétard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8321-6. Epub 2005 May 26.

18.

A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.

Caval V, Suspène R, Shapira M, Vartanian JP, Wain-Hobson S.

Nat Commun. 2014 Oct 9;5:5129. doi: 10.1038/ncomms6129.

PMID:
25298230
19.

AID-initiated DNA lesions are differentially processed in distinct B cell populations.

Chen Z, Ranganath S, Viboolsittiseri SS, Eder MD, Chen X, Elos MT, Yuan S, Hansen E, Wang JH.

J Immunol. 2014 Dec 1;193(11):5545-56. doi: 10.4049/jimmunol.1401549. Epub 2014 Oct 22. Erratum in: J Immunol. 2015 Feb 1;194(3):1383. Yuan, Shunzhong [corrected Yuan, Shunzong].

20.

APOBEC3B is an enzymatic source of mutation in breast cancer.

Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, Law EK, Harris RS.

Nature. 2013 Feb 21;494(7437):366-70. doi: 10.1038/nature11881. Epub 2013 Feb 6. Erratum in: Nature. 2013 Oct 24;502(7472):580.

Supplemental Content

Support Center